FCBT
TGTX icon

First Citizens Bank & Trust’s TG Therapeutics TGTX Stock Holding History

First Citizens Bank & Trust’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$991K Buy
18,033
+4,056
+29% +$166K 0.01% 327
2026
Q1 		$464K Sell
13,977
-433
-3% -$12.9K 0.01% 453
2025
Q4 		$430K Sell
14,410
-618
-4% -$20.2K 0.01% 466
2025
Q3 		$543K Sell
15,028
-595
-4% -$19.6K 0.01% 416
2025
Q2 		$562K Buy
15,623
+10,268
+192% +$382K 0.01% 407
2025
Q1 		$211K Buy
+5,355
New +$180K 0.01% 478

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

First Citizens Bank & Trust's TGTX Position: Q2 2026 in Review

First Citizens Bank & Trust increased its TG Therapeutics (TGTX) stake by 29% in Q2 2026, buying an estimated $166K and bringing the position to 18,033 shares worth $991K. The position accounts for 0.01% of the portfolio, ranked #327.

First Citizens Bank & Trust first reported a position in TGTX in Q1 2025 and has held it in 6 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • First Citizens Bank & Trust held 18,033 shares of TG Therapeutics worth $991K as of Q2 2026.
  • First Citizens Bank & Trust bought 4,056 TG Therapeutics shares in Q2 2026, an estimated $166K.
  • TG Therapeutics made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #327 holding.
  • First Citizens Bank & Trust first reported a position in TG Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.